InMed Pharmaceuticals Inc (INM) — Cash Flow-to-Debt Ratio
InMed Pharmaceuticals Inc (INM) has a Cash Flow-to-Debt Ratio of 0.00x as of March 2026, meaning its operating cash flow of $-1.76 Million could theoretically repay 0% of its total liabilities ($2.24 Billion) in one year. See INM free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
InMed Pharmaceuticals Inc Cash Flow-to-Debt Ratio (2001–2025)
Historical debt coverage capacity for InMed Pharmaceuticals Inc across 25 annual periods. Also explore net asset momentum of InMed Pharmaceuticals Inc to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for InMed Pharmaceuticals Inc (2001–2025)
Year-by-year debt coverage analysis for InMed Pharmaceuticals Inc. For market capitalisation and broader financial context, see INM market cap.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -2.66x | $-7.77 Million | $2.92 Million | ▼ -36.1% |
| 2024 | -1.95x | $-6.99 Million | $3.58 Million | ▲ +28.4% |
| 2023 | -2.73x | $-7.28 Million | $2.67 Million | ▲ +16.5% |
| 2022 | -3.26x | $-15.58 Million | $4.78 Million | ▲ +0.9% |
| 2021 | -3.29x | $-9.79 Million | $2.97 Million | ▲ +14.1% |
| 2020 | -3.83x | $-7.37 Million | $1.92 Million | ▲ +31.7% |
| 2019 | -5.61x | $-6.68 Million | $1.19 Million | ▼ -8.8% |
| 2018 | -5.16x | $-3.68 Million | $713.02K | ▲ +38.0% |
| 2017 | -8.32x | $-2.37 Million | $284.24K | ▼ -883.3% |
| 2016 | -0.85x | $-386.07K | $456.17K | ▲ +96.7% |
| 2015 | -25.72x | $-1.61 Million | $62.51K | ▼ -181.1% |
| 2014 | -9.15x | $-641.38K | $70.11K | ▼ -1046.5% |
| 2013 | -0.80x | $-39.26K | $49.20K | ▲ +79.6% |
| 2012 | -3.92x | $-174.62K | $44.59K | ▲ +67.8% |
| 2011 | -12.16x | $-562.06K | $46.20K | ▼ -7854.5% |
| 2010 | -0.15x | $-195.42K | $1.28 Million | ▼ -260.5% |
| 2009 | 0.10x | $100.48K | $1.05 Million | ▲ +115.2% |
| 2008 | -0.63x | $-951.15K | $1.52 Million | ▲ +39.3% |
| 2007 | -1.03x | $-1.40 Million | $1.35 Million | ▼ -103.0% |
| 2006 | -0.51x | $-577.40K | $1.14 Million | ▼ -19.7% |
| 2005 | -0.42x | $-702.23K | $1.66 Million | ▲ +31.5% |
| 2004 | -0.62x | $-484.19K | $781.44K | ▲ +32.4% |
| 2003 | -0.92x | $-844.62K | $921.99K | ▲ +94.0% |
| 2002 | -15.36x | $-1.14 Million | $74.45K | ▼ -1505.2% |
| 2001 | -0.96x | $-471.69K | $493.02K | — |